Key facts
- Fitspire’s last known valuation is $5.1M (Aug 2023).
- It has raised $2.4M; the latest was Later Stage VC ($1.0M) in Feb 2025.
- Notable investors include Venture Garage, Ruchirans and Anuraag Jaipuria Family Office, Amit Singhal, Anant Agarwal, Ashish Chand — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Fitspire
- ·The full record, as it builds
Funding rounds
No funding rounds for Fitspire are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fitspire
Producer of health and fitness supplements intended to provide nutrition. The company's products include plant and whey protein, men's and women's multivitamins, keto capsules, immunity booster tablets, and curcumin tablets which are vegan and vegetarian, paraben-free, and with no added colors, enabling consumers to get proper nutrition without any side effects.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New Delhi, India
- Founded
- 2019
- Employees
- 4
- Website
- fitspire.online/
- Ownership
- Privately Held (backing)
Fitspire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fitspire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fitspire in its N-PORT filings yet. We sweep new filings monthly.